Coffee intake by myocardial infarction patients showed a significant reduced rate of mortality, a renowned institute study postulated.
Myocardial infarction is another term of heart attack.
Coffee, a popular and social beverage all over the world, particularly in the West, is a drink made from roasted bean from the Coffea plant, native to tropical Africa and Madagascar.
In a study of 4365 Dutch patients from the Alpha Omega Cohort, aged 60-80 y (21% female) and experienced an MI <10 y before study enrollment, using baseline (2002-2006), to evaluate the dietary data including coffee consumption over the past month collected and 203-item validated food-frequency questionnaire, after examine the returned questionnaire from participants, researchers indicated that
1. Most of patients(96%) were coffee drinkers
2. Intake of coffee >4 cups/d, regularly and daily expressed a inverse association to risk of mortality in compared to 0-2 cups/d.
3. Motility risk after myocardial infarction (MI) was decreased for every cup of additional coffee intake
Interesting, researchers also found out that there were no risk difference between caffeine and decaffeinated coffee.
Additionally, in the review of literature in the data base of MEDLINE and Embase published between 1946 and 2015, 2 eligible studies iinvolved-AMI mortality risk against coffee consumption with a total of 3271 patients and 604 died, in patients classified as light coffee drinkers (1-2 cups/day) versus noncoffee drinkers, heavy coffee drinkers (a>2 cups/day) versus noncoffee drinkers and heavy coffee drinkers versus light coffee drinkers, scientists filed the following results
1. All groups showed a significant reduction in risk ratio in compared to non drinkers.
2. The hazard risk ratio was 0.79 in light coffee drinkers versus noncoffee drinkers.
3. The risk ratio of 0.54 was found in Heavy coffee drinkers versus noncoffee drinkers and
4. Heavy coffee drinkers versus light coffee drinkers were associated with a risk ratio of 0.69
Most important, even though habitual coffee consumption exerted a enormous effect in reduced risk
coronary heart disease, congestive heart failure, arrhythmias, and stroke as well as reduced risks of mortality, but most of the data on coffee's health effects are based on observational examine with very few randomized, controlled studies, and association does not prove causation, therefore while addressing the possible advantages of regular coffee consumption, researchers must also take into account of potential, risk such as anxiety, insomnia, tremulousness, and palpitations.
You Can Eliminate Osteoarthritis
By addressing the Underlying Causes through Clinical Trials and Studies
Ovarian Cysts And PCOS Elimination
Holistic System In Existence That Will Show You How To
Permanently Eliminate All Types of Ovarian Cysts Within 2 Months
FOOD HACK for Weight Loss
A Simple Cooking Technique That Cuts The Calories & Glycemic
Impact In Rice, Pasta, And Potatoes In Half
Kyle J. Norton, Master of Nutrients
Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.
(1) Coffee consumption after myocardial infarction and risk of cardiovascular mortality: a prospective analysis in the Alpha Omega Cohort by van Dongen LH1, Mölenberg FJ1, Soedamah-Muthu SS1, Kromhout D1,2, Geleijnse JM3.(PubMed)
(2) Coffee reduces the risk of death after acute myocardial infarction: a meta-analysis by Brown OI1, Allgar V, Wong KY.(PubMed)
(3) Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality by O'Keefe JH1, Bhatti SK, Patil HR, DiNicolantonio JJ, Lucan SC, Lavie CJ.(PubMed)